Literature DB >> 18790058

Evaluation of age and sex differences in locomotion and catalepsy during repeated administration of haloperidol and clozapine in adolescent and adult rats.

Jenny L Wiley1, Rhys L Evans.   

Abstract

Adolescence is associated with characteristic behavioral patterns as well as with substantial neuronal pruning and re-organization of the brain. Recent research has determined that the effects of various centrally active drugs differ in adolescents and adults. This study examined the motor effects of two prototypic antipsychotics in adult [>postnatal day 70 (PN70)] and adolescent (PN30-PN39) rats. Rats were injected daily with saline, 0.3 mg/kg haloperidol, or 10 mg/kg clozapine for 10 days and activity and catalepsy were measured. Adolescents of both sexes were less sensitive to the cataleptic effects of haloperidol than were adults. Male adolescents were also less sensitive to the cataleptic effects of clozapine, although this difference was transitory. In contrast, female adults showed decreased sensitivity to clozapine's effects, differing from all other groups. These results suggest that adolescents of both sexes may be less sensitive to the extrapyramidal motor effects of haloperidol. Translational implications of the clozapine results are less clear; however, results suggest that developmental differences in neurochemical systems affected by clozapine that are also related to motor behavior may play a role. These results also emphasize the importance of age and sex as determinants of the pharmacological effects of these antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790058      PMCID: PMC2586081          DOI: 10.1016/j.phrs.2008.08.002

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  34 in total

1.  Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice.

Authors:  V M Simón; A Parra; J Miñarro; M C Arenas; C Vinader-Caerols; M A Aguilar
Journal:  Eur Neuropsychopharmacol       Date:  2000-05       Impact factor: 4.600

2.  Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction.

Authors:  Susan L Andersen; Andrew P Thompson; Eileen Krenzel; Martin H Teicher
Journal:  Psychoneuroendocrinology       Date:  2002-08       Impact factor: 4.905

3.  Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats.

Authors:  Wenxia Zhou; Kathryn A Cunningham; Mary L Thomas
Journal:  Brain Res Mol Brain Res       Date:  2002-04-30

4.  Chronic administration of haloperidol during development: later psychopharmacological responses to apomorphine and arecoline.

Authors:  I A Shalaby; L P Spear
Journal:  Pharmacol Biochem Behav       Date:  1980-11       Impact factor: 3.533

Review 5.  Atypical antipsychotics: mechanism of action.

Authors:  Philip Seeman
Journal:  Can J Psychiatry       Date:  2002-02       Impact factor: 4.356

6.  Cocaine differentially alters behavior and neurochemistry in periadolescent versus adult rats.

Authors:  Stephanie L Collins; Sari Izenwasser
Journal:  Brain Res Dev Brain Res       Date:  2002-09-20

7.  FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol.

Authors:  Monte S Buchsbaum; M Mehmet Haznedar; Jonathan Aronowitz; Adam M Brickman; Randall E Newmark; Rachel Bloom; Jesse Brand; Kim E Goldstein; Desmond Heath; Meghan Starson; Erin A Hazlett
Journal:  Schizophr Res       Date:  2007-06-15       Impact factor: 4.939

8.  Effects of maturation and aging on behavioral responses to haloperidol in the rat.

Authors:  A Campbell; R J Baldessarini
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Cannabinoid pharmacological properties common to other centrally acting drugs.

Authors:  Jenny L Wiley; Billy R Martin
Journal:  Eur J Pharmacol       Date:  2003-06-27       Impact factor: 4.432

10.  Chronic administration of haloperidol during development: behavioral and psychopharmacological effects.

Authors:  L P Spear; I A Shalaby; J Brick
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  11 in total

1.  Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain.

Authors:  Caitlin E McOmish; Alena Lira; James B Hanks; Jay A Gingrich
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

2.  Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.

Authors:  Janitza L Montalvo-Ortiz; Daniel W Fisher; Guadalupe Rodríguez; Deyu Fang; John G Csernansky; Hongxin Dong
Journal:  Psychopharmacology (Berl)       Date:  2017-04-18       Impact factor: 4.530

3.  Delayed yet persistent effects of daily risperidone on activity in developing rats.

Authors:  Rachel M Stevens; Matthew A Gannon; Molly S Griffith; Mark E Bardgett
Journal:  Behav Pharmacol       Date:  2016-08       Impact factor: 2.293

4.  Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice.

Authors:  J E de Leeuw van Weenen; E T Parlevliet; J P Schröder-van der Elst; S A van den Berg; K Willems van Dijk; J A Romijn; H Pijl
Journal:  Exp Diabetes Res       Date:  2011-04-06

5.  To breed or not to breed? Empirical evaluation of drug effects in adolescent rats.

Authors:  Jenny L Wiley; Rhys L Evans
Journal:  Int J Dev Neurosci       Date:  2008-11-08       Impact factor: 2.457

Review 6.  Group II metabotropic glutamate receptors and schizophrenia.

Authors:  José L Moreno; Stuart C Sealfon; Javier González-Maeso
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

7.  Adult rats treated with risperidone during development are hyperactive.

Authors:  Mark E Bardgett; Julie M Franks-Henry; Kristin R Colemire; Kathleen R Juneau; Rachel M Stevens; Cecile A Marczinski; Molly S Griffith
Journal:  Exp Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.157

8.  Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model.

Authors:  Jing Qiao; Hong Li; Ming Li
Journal:  Neuropsychopharmacology       Date:  2012-11-07       Impact factor: 7.853

Review 9.  Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs.

Authors:  Serge Mignani; Xiangyang Shi; Andrii Karpus; Jean-Pierre Majoral
Journal:  Eur J Med Chem       Date:  2020-10-11       Impact factor: 6.514

10.  Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice.

Authors:  Hiroshi Ueno; Shunsuke Suemitsu; Shinji Murakami; Naoya Kitamura; Kenta Wani; Yu Takahashi; Yosuke Matsumoto; Motoi Okamoto; Takeshi Ishihara
Journal:  Libyan J Med       Date:  2020-12       Impact factor: 1.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.